首页> 外文期刊>Clinical ophthalmology >Does titration of mitomycin C as an adjunct to trabeculectomy significantly influence the intraocular pressure outcome?
【24h】

Does titration of mitomycin C as an adjunct to trabeculectomy significantly influence the intraocular pressure outcome?

机译:滴定丝裂霉素C作为小梁切除术的辅助措施是否会显着影响眼压结果?

获取原文
           

摘要

Purpose: To evaluate the benefit of titrating the concentration and exposure time of mitomycin C (MMC) as an adjunct to trabeculectomy.Methods: This report consists of a retrospective study and a review of the literature. In the study, consecutive glaucoma patients were evaluated who underwent trabeculectomy with adjunctive MMC that was titrated for concentration and exposure time, based on patient’s risk factors for surgical failure. After minimum follow-up of 6 months, patients were divided into success (intraocular pressure 7–17 mmHg), hypertension (>17 mmHg) and hypotony ( 0.05). The only significant patient variable was older age in the hypotony group (p = 0.009). The literature is conflicting regarding the value of titrating MMC as an adjunct in trabeculectomy.Conclusion: The outcome of trabeculectomy with adjunctive MMC appears to represent a complex interaction of patient and surgical variables. While there is some support for a benefit of titrating MMC according to individual patient variables, there is inadequate evidence at the present time to claim superiority for any MMC protocol, with or without titration.
机译:目的:评估滴定丝裂霉素C(MMC)作为小梁切除术的辅助手段的益处。方法:本报告包括回顾性研究和文献综述。在这项研究中,根据患者手术失败的风险因素,对连续性青光眼患者进行了评估,这些患者接受了辅助性MMC小梁切除术,并根据浓度和暴露时间进行了滴定。至少随访6个月后,将患者分为成功(眼压7-17 mmHg),高血压(> 17 mmHg)和肌张力低下(0.05)。唯一重要的患者变量是低渗组的年龄较大(p = 0.009)。关于滴定MMC作为小梁切除术辅助手术的价值的文献存在争议。结论:小梁切除术与辅助MMC的结果似乎代表了患者和手术变量之间的复杂相互作用。虽然有人支持根据个体患者变量进行MMC滴定的好处,但目前尚无足够证据证明有或没有滴定的任何MMC方案都具有优势。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号